Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 1/20 | 0.55 |
| ▸ | MAOB | P27338 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | DRD2 | P14416 | 3/20 | 0.47 |
| ▸ | CA1 | P00915 | 4/20 | 0.47 |
| ▸ | CA2 | P00918 | 4/20 | 0.47 |
| ▸ | CA12 | O43570 | 3/20 | 0.47 |
| ▸ | CA9 | Q16790 | 3/20 | 0.47 |
| ▸ | SLC2A1 | P11166 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | PIM1 | P11309 | 1/20 | 0.45 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL976700 | 1.00 | MAOA (0.55) | MAOAMAOBTDP1CYP3A4DRD2 | |
| SCHEMBL30442477 | 0.89 | MAOA (0.44) | MAOAMAOBTDP1CYP3A4DRD2 | |
| SCHEMBL975698 | 0.89 | MAOA (0.44) | MAOAMAOBTDP1CYP3A4DRD2 | |
| SCHEMBL15134867 | 0.88 | CA14 (0.47) | MAOAMAOBTDP1CYP3A4DRD2 | |
| SCHEMBL977328 | 0.88 | BRD4 (0.44) | MAOAMAOBTDP1CYP3A4DRD2 | |
| SCHEMBL3291371 | 0.87 | KDM4A (0.47) | MAOAMAOBTDP1CYP3A4DRD2 | |
| SCHEMBL16151782 | 0.85 | MAOA (0.56) | MAOAMAOBTDP1CYP3A4CA1 | |
| SCHEMBL13426175 | 0.83 | ATM (0.55) | MAOAMAOBTDP1CYP3A4CA1 | |
| SCHEMBL15586616 | 0.82 | KDM4A (0.49) | CYP3A4DRD2 | |
| SCHEMBL7110040 | 0.81 | MAOA (0.57) | MAOAMAOBTDP1CYP3A4CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1490359-B1 | DETECTION OF GLUCOSE IN SOLUTIONS ALSO CONTAINING AN ALPHA-HYDROXY ACID OR A BETA-DIKETONE | SENSORS FOR MED & SCIENCE INC (US) | 2010-05-19 | — | — | EP | disclosed |
| EP-1490359-A4 | DETECTION OF GLUCOSE IN SOLUTIONS ALSO CONTAINING AN ALPHA-HYDROXY ACID OR A BETA-DIKETONE | SENSORS FOR MED & SCIENCE INC (US) | 2006-08-23 | — | — | EP | disclosed |
| US-7078554-B2 | Detection of glucose in solutions also containing an alpha-hydroxy acid or a beta-diketone | SENSORS FOR MEDICINE AND SCIENCE, INC. (US) | 2006-07-18 | — | — | US | disclosed |
| US-20050043275-A1 | Detection of glucose in solutions also containing an alpha-hydroxy acid or a beta-diketone | SENSEONICS, INCORPORATED | 2005-02-24 | — | — | US | disclosed |
| EP-1490359-A1 | DETECTION OF GLUCOSE IN SOLUTIONS ALSO CONTAINING AN ALPHA-HYDROXY ACID OR A BETA-DIKETONE | Sensors for Medicine and Science, Inc. (US) | 2004-12-29 | — | — | EP | disclosed |
| US-6800451-B2 | MORE STABLE REACTION OF GLUCOSE WITH A BORONIC ACID COMPOUND SUCH AS 9,10-BISN-(BORONOBENZYL)-N-(3-(METHYACRYLAMIDO) PROPYLAMINO)METHYLANTHRACENE | SENSORS FOR MEDICINE AND SCIENCE, INC. | 2004-10-05 | — | — | US | disclosed |
| EP-1388014-A2 | DETECTION OF GLUCOSE IN SOLUTIONS | Sensors for Medicine and Science, Inc. (US) | 2004-02-11 | — | — | EP | disclosed |
| WO-2003078424-A1 | DETECTION OF GLUCOSE IN SOLUTIONS ALSO CONTAINING AN ALPHA-HYDROXY ACID OR A BETA-DIKETONE | SENSORS FOR MEDICINE AND SCIENCE, INC. (US) | 2003-09-25 | — | — | WO | disclosed |
| US-20030082663-A1 | Detection of glucose in solutions also containing an alpha-hydroxy acid or a beta-diketone | SENSORS FOR MEDICINE AND SCIENCE, INC. | 2003-05-01 | — | — | US | disclosed |
| US-20020127626-A1 | Detection of glucose in solutions also containing an alpha-hydroxy acid or a beta-diketone | SENSORS FOR MEDICINE AND SCIENCE, INC. | 2002-09-12 | — | — | US | disclosed |
| WO-2002057788-A2 | DETECTION OF GLUCOSE IN SOLUTIONS ALSO CONTAINING AN ALPHA-HYDROXY ACID OR A BETA-DIKETONE | SENSORS FOR MEDICINE AND SCIENCE, INC. (US) | 2002-07-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050043275-A1 | Detection of glucose in solutions also containing an alpha-hydroxy acid or a beta-diketone | GCK, KHK, HK1 | MAOA 2276/4885MAOB 2502/4885TDP1 3492/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.